Corporate News Report – Cosmos Health Inc.
Market Performance
- Closing price: USD 0.26 (traded down 9.96 % during the 24‑hour period ending 11:25 PM Central Europe, Friday 23rd).
- Shares outstanding: 60 million.
- Market capitalization: USD 28.3 million.
- Volume (last 24 h): USD 490.8 k.
- Monthly change: down 37.84 % since the previous month’s end.
- 200‑day simple moving average: USD 0.32.
- 52‑week range: high USD 1.05 (27 Oct 2025), low USD 0.16 (30 Jun 2026).
Recent Company Announcements
Cosmos Health Inc. announced that its e‑commerce and subscription platform has expanded to Australia, New Zealand and the wider Oceania region, with sales already underway in those markets. The U.S. direct‑to‑consumer business continues to grow; active subscriptions have risen sharply in recent days, and revenue from that channel is projected to represent a large portion of the quarter’s earnings.
In its latest shareholder letter, the company highlighted record revenue for the first nine months of 2026, a strong outlook for the full year, and continued expansion of its proprietary brands and contract‑manufacturing operations. Cosmos Health outlined a strategy to increase gross margins through a shift toward higher‑margin proprietary products and to broaden its recurring customer base via the subscription model.
Leadership noted ongoing investment in research and development, including a weight‑management device and an AI‑driven drug‑repurposing platform. These initiatives support the company’s broader goal of building a globally integrated healthcare platform.
Related Stock Performance (Last 24 Hours)
| Ticker | Change | Current Price | Market Cap |
|---|---|---|---|
| LSF – Laird Superfood | –5.4 % | USD 2.76 | USD 33.4 million |
| BOF – Branchout Food /Or | –2.29 % | USD 2.02 | USD 32.6 million |
| IGCRF – Integrated Quantum Technologies | –7.28 % | USD 0.27 | USD 33.6 million |
| CELU – Celularity | –19.05 % | USD 0.98 | USD 33.1 million |
| QTI – Qt Imaging | –0.86 % | USD 2.25 | USD 33.8 million |
Key developments for related companies:
Branchout Food /Or (BOF) reported a shift toward a more predictable revenue model, with record Q4 expectations of $6–7 million and an annualized run rate of roughly $26 million. The company attributes growth to expanded industrial ingredient contracts and new retail launches. Production capacity increased to a monthly output of 55,000 kg in September, targeting 60,000–70,000 kg in Q4. A planned common‑stock offering in October aims to fund expansion without additional debt.
Integrated Quantum Technologies (IGCRF) announced a partnership with Florida‑based ARMI Solutions to broaden its U.S. government market strategy. The non‑exclusive reseller agreement will introduce the company’s VEIL technology to federal agencies, prime contractors, and technology providers, supporting AI adoption while safeguarding sensitive data.
Celularity (CELU) restored compliance with Nasdaq listing requirements, including timely filing of financial reports and minimum bid price/market‑value thresholds. The company emphasized strengthening its finance organization and establishing a disciplined reporting process. Earnings per share were modest, and revenue showed a slight decline compared with the same quarter a year earlier.
Company Overview
Cosmos Health, Inc. is a pharmaceutical company that specializes in identifying, acquiring, developing, and commercializing generic pharmaceuticals, nutraceuticals, over‑the‑counter medications, and medical devices. These products are designed to enhance patients’ lives and outcomes globally.
